OTCMKTS:GTHP Guided Therapeutics (GTHP) Stock Forecast, Price & News $0.16 +0.06 (+51.33%) (As of 05:34 PM ET) Add Compare Share Share Today's Range$0.09▼$0.1650-Day Range$0.11▼$0.2852-Week Range$0.06▼$0.60Volume20,026 shsAverage Volume24,855 shsMarket Capitalization$8.41 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest About Guided Therapeutics (OTCMKTS:GTHP) StockGuided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. It also focuses on the selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The company was founded by Shabbir Bakir Bambot and Mark L. Faupel on October 27, 1992 and is headquartered in Norcross, GA.Read More Receive GTHP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GTHP Stock News HeadlinesMay 11, 2023 | americanbankingnews.comShort Interest in Guided Therapeutics, Inc. (OTCMKTS:GTHP) Rises By 17,700.0%April 20, 2023 | americanbankingnews.comContrasting AxoGen (NASDAQ:AXGN) and Guided Therapeutics (OTCMKTS:GTHP)June 9, 2023 | Vantage Point (Ad)Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I.There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market. March 21, 2023 | americanbankingnews.comFinancial Contrast: Guided Therapeutics (OTCMKTS:GTHP) & Fc Global Realty (OTCMKTS:FCRE)February 17, 2023 | abcnews.go.com'It was a trap': Video shows American volunteer likely killed by guided missile in 'deliberate' Russian attackNovember 9, 2022 | finance.yahoo.comGuided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical ScanJuly 20, 2022 | finance.yahoo.comGuided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical ScanJune 9, 2022 | finance.yahoo.comImpel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache SocietyJune 9, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.May 18, 2022 | stockhouse.comOlive Resource Capital Announces Agreement to Acquire C$2.5M Portfolio of AssetsMarch 31, 2022 | finance.yahoo.comGuided Therapeutics Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740November 17, 2021 | finance.yahoo.comGuided Therapeutics Announces Start of Chinese Clinical Trial for Approval to Market and Sell LuViva in ChinaOctober 5, 2021 | finance.yahoo.comGuided Therapeutics Ships LuViva Devices to China for Start of Clinical Trial; Receives Additional $100,000 PaymentOctober 26, 2020 | businesswire.comCompany Profile for Guided Therapeutics, Inc.See More Headlines GTHP Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GTHP Company Calendar Today6/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GTHP CUSIPN/A CIK924515 Webwww.guidedinc.com Phone(770) 242-8723Fax770-242-8639Employees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,340,000.00 Net Margins-4,276.71% Pretax Margin-15,676.67% Return on EquityN/A Return on Assets-161.73% Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.49 Sales & Book Value Annual Sales$10,000.00 Price / Sales555.50 Cash FlowN/A Price / Cash FlowN/A Book Value($0.12) per share Price / Book-0.91Miscellaneous Outstanding Shares51,010,000Free Float16,920,000Market Cap$5.55 million OptionableNot Optionable Beta0.62 Key ExecutivesMark L. FaupelPresident, Chief Executive Officer & DirectorRichard L. FowlerSenior Vice President-EngineeringKey CompetitorsYubo International BiotechOTCMKTS:YBGJMicron SolutionsOTCMKTS:MICRENDRA Life SciencesNASDAQ:NDRANon-Invasive Monitoring SystemsOTCMKTS:NIMUHelius Medical TechnologiesNASDAQ:HSDTView All Competitors GTHP Stock - Frequently Asked Questions How have GTHP shares performed in 2023? Guided Therapeutics' stock was trading at $0.30 on January 1st, 2023. Since then, GTHP shares have decreased by 63.7% and is now trading at $0.1089. View the best growth stocks for 2023 here. Are investors shorting Guided Therapeutics? Guided Therapeutics saw a drop in short interest in May. As of May 15th, there was short interest totaling 7,700 shares, a drop of 56.7% from the April 30th total of 17,800 shares. Based on an average daily trading volume, of 118,100 shares, the days-to-cover ratio is currently 0.1 days. View Guided Therapeutics' Short Interest. What is Guided Therapeutics' stock symbol? Guided Therapeutics trades on the OTCMKTS under the ticker symbol "GTHP." How do I buy shares of Guided Therapeutics? Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Guided Therapeutics' stock price today? One share of GTHP stock can currently be purchased for approximately $0.11. How much money does Guided Therapeutics make? Guided Therapeutics (OTCMKTS:GTHP) has a market capitalization of $5.55 million and generates $10,000.00 in revenue each year. How can I contact Guided Therapeutics? Guided Therapeutics' mailing address is 5835 PEACHTREE CORNERS EAST SUITE D, PEACHTREE CORNERS GA, 30092. The official website for the company is www.guidedinc.com. The company can be reached via phone at (770) 242-8723, via email at bwells@guidedinc.com, or via fax at 770-242-8639. This page (OTCMKTS:GTHP) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.